Karen Aiach

Biography

 Karen Aiach is the founder and CEO of Lysogene, a pioneering and listed biotechnology company active in fundamental research and the clinical development of gene therapies for central nervous system diseases. Karen has extensive business acumen having begun her career with Arthur Andersen, where she worked for seven years in audit services and international transactions, before setting up and running her own financial services firm. Karen has also served as a patient representative and member of the Paediatric Committee of the European Medicines Agency (EMA). She is a founding and executive member of the International Rare Diseases Research Consortium (IRDiRC). Karen holds a DEA postgraduate diploma from University of Paris VIII and is a graduate of ESSEC Business School.

Research Interest

 Biochemistry, Biotechnology